2024-03-05 12:57:03 ET
2Seventy Bio, Inc. (TSVT)
Q4 2023 Earnings Conference Call
March 05, 2024, 08:00 ET
Company Participants
Elizabeth Hickin - Head, IR
Chip Baird - Incoming CEO
Vicki Eatwell - Incoming CFO
Anna Truppel-Hartmann - SVP, Clinical Development
Conference Call Participants
Daina Graybosch - Leerink Partners
Tommie Reerink - Goldman Sachs & Co.
Kelsey Goodwin - Guggenheim Securities
Samantha Semenkow - Citigroup
Presentation
Operator
Good day, and thank you for standing by. Welcome to the 2seventy bio fourth-quarter 2023 earnings conference call. [Operator Instructions].
Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker, Elizabeth Hickin, Head of Investor Relations. Please go ahead....
Read the full article on Seeking Alpha
For further details see:
2Seventy Bio, Inc. (TSVT) Q4 2023 Earnings Call Transcript